Quantcast

Posts related to ‘Cult Stock’

5 Unusual Against-The-Grain Winners (ALU, GDX, PCX, ROSG, SCHS)

The market was down significantly earlier in the day with a double-digit S&P 500 drop and a triple-digit drop in the DJIA.  We wanted to see some unusual gainers on ...
Read Full Story »

Shareholders Shouldn’t ‘Like’ Zuckerberg’s Wedding (FB)

Here is a recipe for you to consider: The biggest Internet IPO of all time, and making it a flop. Huge insider selling. Increase the price range and increase the ...
Read Full Story »

Facebook Flirts With Busted IPO Status (FB)

Facebook, Inc. (NASDAQ: FB) has been a significant debut, and it has had some surprises even if we are about as sick of hearing this name as one could imagine.  ...
Read Full Story »

Live Blog of Facebook IPO (Updated Throughout The Day)

Facebook, Inc. (NASDAQ: FB) is finally public.  After pricing about 421 million shares at $38.00, the company raised $16 billion without taking into consideration the green-shoe or overallotment option for ...
Read Full Story »

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA)

We are now just about two weeks away from the king of biotech and pharma events in cancer treatments.  The 2012 annual meeting of the American Society of Clinical Oncology (ASCO) ...
Read Full Story »

Blue Nile Loses Head of Merchandising & Diamond Supply

Blue Nile Inc. (NASDAQ: NILE) is losing a key member of its merchandising team.  The online jewelry, diamond, and raw stone destination has a filing with the Securities and Exchange ...
Read Full Story »

In Defense of Molycorp and Rare Earths

Molycorp Inc. (NYSE: MCP) is nothing short of an odd stock in an even more odd industry.  Most investors and most in the public might not even understand what rare ...
Read Full Story »

Can A European Approval of Pixantrone Save Cell Therapeutics? (CTIC)

Cell Therapeutics, Inc. (NASDAQ: CTIC) is about as controversial of a biotech stock as there can be.  It often traded huge volume around drug approval or study news, and shares ...
Read Full Story »

Key Short Interest Changes in Cult Stocks & Controversial Stocks (ALU, STD, BAC, BKS, DNDN, DMND, FSLR, GMCR, GRPN, HGSI, LNKD, NFLX, RSH, RIMM, SIRI)

The short interest data is out using the April 30 settlement date.  We have seen some drastic changes from the April 13 settlement date in many issues, followed by some ...
Read Full Story »

A Strange Rare Earth Segment Move… Opportunity or Trap? (MCP, REE, AVL, REMX)

The trend from rare earth moves usually seems to be like a China-regulatory move, but that is not the case today.  We have an emerging player which has delayed a ...
Read Full Story »

Short Interest Changes in Cult Stocks and Controversial Stocks (ALU, STD, BAC, BKS, DNDN, DMND, FSLR, GMCR, GRPN, HGSI, LNKD, NFLX, NOK, RSH, RIMM, SIRI)

There are more changes in the short interest of some of the key cult stocks and most actively traded and controversial stocks. The start of earnings season may have influenced ...
Read Full Story »

Coinstar’s Higher Guidance Raises Focus On Netflix (CSTR, NFLX)

Coinstar, Inc. (NASDAQ: CSTR) is raising its first quarter and annual earnings and revenue guidance.  The news is going to be particularly important for Netflix, Inc. (NASDAQ: NFLX) because of ...
Read Full Story »

Short Interest Changes in Cult Stocks & Controversial Stocks (ALU, BAC, DNDN, DMND, FSLR, GMCR, HGSI, LNKD, NFLX, RSH, RIMM, SIRI)

It is no secret that cult stocks and controversial stocks often have an unusually high short interest.  The markets rose handily into the end of March and that has shown ...
Read Full Story »

A Financial Reality Check For Diamond Foods (DMND)

There is a good reality check today for anyone considering whether or not they should be committing capital to invest in Diamond Foods, Inc. (NASDAQ: DMND).  The nuts and snacks ...
Read Full Story »

SecondMarket Launches ‘The Facebook Fund’ To Buy Shares Before IPO (FB, GSVC)

SecondMarket is taking a new approach to allowing investors to buy into Facebook ahead of the upcoming IPO, and it is quite different from any efforts to date from this ...
Read Full Story »